Table 2.
Maternal outcomes in the hepatitis C virus viremic group vs the control group
|
Variables, n (%)
|
HCV-infected group (n = 79), %
|
Healthy mother group (n = 115), %
|
P
value
|
| Pregnancy complications | |||
| Preterm (< 37 wk) | 1/79 (1.3) | 0/115 (0.0) | > 0.99 |
| Preeclampsia | 3/79 (3.8) | 0/115 (0.0) | 0.07 |
| Eclampsia | 0/79 (0.0) | 2/115 (2.5) | 0.17 |
| Gestational hypertension | 0/79 (0.0) | 4/115 (3.5) | 0.15 |
| Abnormal thyroid function | 4/79 (5.1) | 1/115 (0.9) | 0.16 |
| Gestational diabetes | 4/79 (5.1) | 4/115 (3.5) | 0.72 |
| Oligohydramnios | 6/79 (7.6) | 3/115 (2.6) | 0.16 |
| Abnormal renal function | 49/79 (62.0) | 64/115 (55.7) | 0.38 |
| Anemia during pregnancy | 15/79 (19.0) | 3/115 (2.6) | < 0.001 |
| Obstetric complications | |||
| Rates of cesarean section1 | 38/79 (48.1) | 32/115 (27.8) | 0.004 |
| Nuchal cord | 27/79 (34.2) | 11/115 (9.6) | < 0.001 |
| Umbilical cord prolapses | 1/79 (1.3) | 0/115 (0.0) | 0.41 |
| Postpartum hemorrhage | 1/79 (1.3) | 0/115 (0.0) | 0.41 |
| Premature rupture of membranes | 3/79 (3.8) | 4/115 (3.5) | > 0.99 |
1
The rates of cesarean section were calculated based on the number of cases performed due to medical needs. Patients who requested a cesarean section without medical indications were not included.